| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Teleseminars > Teleseminar Basics |
|
Top Adding - Teleseminar Basics
Teleseminars is basically the same as teleconferencing. For those who are unfamiliar with either t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product erm, teleseminars or teleconferencing involve a telephone call among a group of people who usually ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in all phone the same telephone number to be connected to each other. Though it is not a new concept lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the telephone meeting idea has gone through many technological changes through the years. It star here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ed as a simple office conference call among employees in long-distance locations. Today, technolog d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro allows the host or presenter to include training sessions, sales and marketing presentations, Pow ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc er Point Presentations, videos, and much more. They are becoming increasingly popular as people co easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e to realize the cost savings of a teleseminar compared to an in-person presentation. This is espe nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ially true of businesses which have locations not only nationally, but internationally as well. T and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e cost savings in travel alone can more than cover the cost of the equipment and the service itsel ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi . One company has a conference call scheduled weekly between their Delaware office and their offic ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e in Dublin, Ireland. It would be economically unfeasible for everyone to get together in person t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod have a meeting on a weekly, or even monthly, basis. As we look toward the future, teleconferenci cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin g will likely evolve into video conferencing. Videoconferencing is being done more and more widely tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen and it is likely to become commonplace, especially with so many people becoming interested in wor t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ing at home or wanting less travel with their jobs. All of this new technology is wonderful, in i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ts place, but teleconferencing cannot and will not replace the in-person seminar or meeting. The t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products lephone will never replace the personal contacts and relationships that are developed through peop . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e getting together as a group, nor should it. However, teleconferencing does provide a way to brin elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip people together effectively and inexpensively, and it represents an opportunity for entrepreneurs tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Step By Step Video Show Exactly How to Increase Your ClickBank Affiliate Sales Using Adwords PPC Credit Card Debt Consolidation Guide
|